Sign Up

Eli Lilly ups revenue forecast as GLP-1 drugs fuel growth

RTE 1 min read 5 hours ago

Eli Lilly and Co today posted better-than-expected quarterly results and raised its full-year revenue forecast, banking on sustained demand for its blockbuster GLP-1 weight-loss and diabetes drugs.
Read original RTE

More from RTE

Sparan Nua set for Desmond duty
Disney's 'Toy Story 5' fuels streaming business in Q2
Fáilte Ireland spends over €10m on short breaks campaign
Derry City part ways with manager Tiernan Lynch